| ADR Ontology |
| ADR Term |
Leukaemia |
| ADR ID |
BADD_A02505 |
| ADR Hierarchy |
|
| Description |
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH] |
| MedDRA Code |
10024288 |
| MeSH ID |
D007938
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
|
| Synonym |
| Leukaemia | Leukaemia NOS | Leukaemia of unspecified cell type | Leukaemia of unspecified cell type, subacute | Leukaemia unspecified | Leukemia | Leukemia NOS | Leukemia of unspecified cell type | Leukemia of unspecified cell type, other | Leukemia of unspecified cell type, subacute | Other leukaemia of unspecified cell type | Other leukemia | Other leukemia of unspecified cell type | Other leukemia of unspecified cell type without mention of remission | Other specified leukaemia | Other specified leukaemias | Other specified leukemia | Other specified leukemia without mention of remission | Subacute leukaemia NOS | Subacute leukemia of unspecified cell type without mention of remission | Unspecified leukaemia | Unspecified leukemia | Unspecified leukemia without mention of remission | Leukaemia secondary | Leukemia secondary | Leukemia secondary to oncology chemotherapy | Leukemid | Subacute leukemia | Leukaemia secondary to oncology chemotherapy | Subacute leukaemia of unspecified cell type without mention of remission | Unspecified leukaemia without mention of remission | Leukemia unspecified | Treatment related leukemia | Treatment related leukaemia | Leukemias | Leucocythaemia | Leucocythaemias | Leucocythemia | Leucocythemias |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
